NCT01520272
- Conditions
- HPV16 Anitbody Levels Post Vaccination, HPV18 Antibody Levels Post Vaccination
- Locations
-
- District of Nakasangola Kampala, Uganda
Clinical trial condition
Explore clinical trials studying HPV16 Anitbody Levels Post Vaccination. Study availability and eligibility vary by location and protocol.
NCT01520272